BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11219772)

  • 21. Tight association of hepatocellular carcinoma with HBV infection in North China.
    Gao JD; Shao YF; Xu Y; Ming LH; Wu ZY; Liu GT; Wang XH; Gao WH; Sun YT; Feng XL; Liang LM; Zhang YH; Sun ZT
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):46-9. PubMed ID: 15730918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aflatoxins and primary liver cancer--a population based case-control study].
    Zhang MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Nov; 26(6):331-3. PubMed ID: 1303345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of aflatoxin-albumin adducts in human serum and its application].
    Sun G; He X; Qian G; Pu Y
    Wei Sheng Yan Jiu; 2001 May; 30(3):185-8. PubMed ID: 12525098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction among the relative risk factors of primary liver cancer in a case-control study].
    Zhao N; Yu S; Sun WM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):90-3. PubMed ID: 7923340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology of malignant liver tumors].
    Rodella S; Picoco C
    Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan.
    Ishiguro S; Inoue M; Tanaka Y; Mizokami M; Iwasaki M; Tsugane S;
    Eur J Cancer Prev; 2009 Feb; 18(1):26-32. PubMed ID: 19077561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of aflatoxin-contaminated food materials and HCV in developing hepatocellular carcinoma in Al-Sharkia Governorate, Egypt.
    Hifnawy MS; Mangoud AM; Eissa MH; Nor Edin E; Mostafa Y; Abouel-Magd Y; Sabee EI; Amin I; Ismail A; Morsy TA; Mahrous S; Afefy AF; el-Shorbagy E; el-Sadawy M; Ragab H; Hassan MI; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):479-88. PubMed ID: 15124754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; SzymaƱska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma.
    Ayoola EA
    IARC Sci Publ; 1984; (63):167-79. PubMed ID: 6100268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary risk factors for primary hepatocellular carcinoma.
    Wogan GN
    Cancer Detect Prev; 1989; 14(2):209-13. PubMed ID: 2559796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure biomarkers in chemoprevention studies of liver cancer.
    Wild CP; Turner PC
    IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
    Ding ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.